博瑞医药：拟1000万-2000万元回购股份，已回购近300万元

Core Viewpoint - The company announced a share repurchase plan aimed at employee stock ownership and equity incentives, with a budget of 10 million to 20 million yuan and a repurchase period until September 25, 2026 [1] Summary by Sections - Share Repurchase Plan - The board approved a share repurchase through centralized bidding [1] - The expected repurchase amount is between 10 million and 20 million yuan [1] - The repurchase period is set from September 26, 2025, to September 25, 2026 [1] - Current Repurchase Status - As of October 31, 2025, the company has repurchased a total of 55,880 shares [1] - This represents 0.0132% of the total share capital [1] - The repurchase price ranged from 52.96 yuan to 54.28 yuan per share [1] - The total funds paid for the repurchase amount to 2,993,933 yuan [1]